Open access
Open access
Powered by Google Translator Translator

Archives

Canadian recommendations on prostate cancer screening and early diagnosis.

6 Apr, 2022 | 09:47h | UTC

UPDATE – 2022 Canadian Urological Association recommendations on prostate cancer screening and early diagnosis: Endorsement of the 2021 Cancer Care Ontario guidelines on prostate multiparametric magnetic resonance imaging – Canadian Urological Association Journal

See also: Summary of changes

 


Review: Antiseizure medications for adults with epilepsy.

6 Apr, 2022 | 10:25h | UTC

Antiseizure Medications for Adults With Epilepsy: A Review – JAMA (free for a limited period)

Audio Clinical Review: Epilepsy Diagnosis and Treatment in Adults – JAMA

 


Cohort Study: Recipient and donor outcomes after living-donor liver transplant for unresectable colorectal liver metastases.

6 Apr, 2022 | 10:23h | UTC

Recipient and Donor Outcomes After Living-Donor Liver Transplant for Unresectable Colorectal Liver Metastases – JAMA Surgery

Commentaries:

Living donation opens new doors for colorectal cancer patients in need of liver transplants – University Health Network

Living-Donor Liver Transplant Promising for CRC With Liver Mets – HealthDay

 

Commentary on Twitter

 


Review: Metabolic flexibility and its impact on health outcomes.

6 Apr, 2022 | 10:08h | UTC

Metabolic Flexibility and Its Impact on Health Outcomes – Mayo Clinic Proceedings

 


Craniocervical artery dissections: a concise review for clinicians.

6 Apr, 2022 | 10:06h | UTC

Craniocervical Artery Dissections: A Concise Review for Clinicians – Mayo Clinic Proceedings

 


RCT: Erythropoietin not beneficial for patients with acute kidney injury.

6 Apr, 2022 | 10:02h | UTC

Erythropoietin in Acute Kidney Injury (EAKI): a pragmatic randomized clinical trial – BMC Nephrology

 


Review: Translational advances in pancreatic ductal adenocarcinoma therapy.

6 Apr, 2022 | 10:05h | UTC

Translational advances in pancreatic ductal adenocarcinoma therapy – Nature Cancer (if the link is paywalled, try this one)

 

Commentary on Twitter

 


M-A: Advanced computed tomographic localization techniques for primary hyperparathyroidism.

6 Apr, 2022 | 09:57h | UTC

Advanced Computed Tomographic Localization Techniques for Primary Hyperparathyroidism: A Systematic Review and Meta-analysis – JAMA Otolaryngology-Head & Neck Surgery (link to abstract – $ for full-text)

 


Opinion: Moving xenotransplantation research into human trials will require adjusting our expectations, researchers say.

6 Apr, 2022 | 09:59h | UTC

Moving xenotransplantation research into human trials will require adjusting our expectations, researchers say – STAT

Related:

After a flurry of firsts, xenotransplantation is suddenly back in the spotlight.

In 1st, US surgeons transplant pig heart into human patient.

 


Review: Fulminant myocarditis in adults.

6 Apr, 2022 | 09:55h | UTC

Fulminant myocarditis in adults: a narrative review – Journal of Geriatric Cardiology

 


RCT: Higher vs. Standard Adalimumab induction and maintenance dosing regimens for treatment of ulcerative colitis.

6 Apr, 2022 | 09:56h | UTC

Higher vs Standard Adalimumab Induction and Maintenance Dosing Regimens for Treatment of Ulcerative Colitis: SERENE UC Trial Results – Gastroenterology

 


Review: Atrial fibrillation in older adults with cancer.

6 Apr, 2022 | 09:53h | UTC

Atrial fibrillation in older adults with cancer – Journal of Geriatric Cardiology

 


Cohort Study: The five major autoimmune diseases are associated with increased risk of cancer.

6 Apr, 2022 | 09:52h | UTC

The five major autoimmune diseases increase the risk of cancer: epidemiological data from a large-scale cohort study in China – Cancer Communications

Commentary: Increased Cancer Risk with Autoimmune Disorders – RheumNow

 


RCT: Rucaparib vs. standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation.

6 Apr, 2022 | 09:45h | UTC

Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial – The Lancet Oncology (link to abstract – $ for full-text)

Commentary: ARIEL4 Trial: Rucaparib vs Chemotherapy in Patients With Relapsed Ovarian Cancer and Deleterious BRCA1 or BRCA2 Mutations – The ASCO Post

 

Commentary on Twitter

 


Registry-based cohort study: Trends in clinical practice and outcomes after percutaneous coronary intervention of unprotected left main coronary artery.

6 Apr, 2022 | 09:50h | UTC

Trends in Clinical Practice and Outcomes After Percutaneous Coronary Intervention of Unprotected Left Main Coronary Artery – Journal of the American Heart Association

Editorial: Is Percutaneous Coronary Intervention Now the Default Revascularization Strategy for Unprotected Left Main Coronary Artery Stenosis? – Journal of the American Heart Association

 


Review: Understanding pediatric ventilation in the operative setting.

6 Apr, 2022 | 08:42h | UTC

Part I: Physical principles of monitoring in the modern anesthesia workstation – Pediatric Anesthesia

Part II: Setting perioperative ventilation – Pediatric Anesthesia

 


Review: Developmental respiratory physiology.

6 Apr, 2022 | 08:41h | UTC

Developmental respiratory physiology – Pediatric Anesthesia

 


Billions of people still breathe unhealthy air: new WHO data.

5 Apr, 2022 | 09:59h | UTC

News Release: Billions of people still breathe unhealthy air: new WHO data – World Health Organization

Report: WHO Air quality Database 2022

Commentaries:

South-East Asia, Africa and Middle East are World’s Air Pollution Hot Spots in WHO’s Largest-Ever Data Release – Health Policy Watch

WHO says 99% of world’s population breathes poor-quality air – Associated Press

Related: New WHO Global Air Quality Guidelines aim to save millions of lives from air pollution.

 

Commentary on Twitter (thread – click for more)

 


Update on ventilatory management of extremely preterm infants—A Neonatal Intensive Care Unit perspective.

6 Apr, 2022 | 08:40h | UTC

Update on ventilatory management of extremely preterm infants—A Neonatal Intensive Care Unit perspective – Pediatric Anesthesia

 


Systematic Review: Videolaryngoscopy vs. direct laryngoscopy for adults undergoing tracheal intubation.

5 Apr, 2022 | 09:52h | UTC

Videolaryngoscopy versus direct laryngoscopy for adults undergoing tracheal intubation – Cochrane Library

 

Commentary from the author on Twitter (thread – click for more)

https://twitter.com/VirtueOfNothing/status/1511007812100390916

 


Review: Novel ventilation techniques in children.

6 Apr, 2022 | 08:38h | UTC

Novel ventilation techniques in children – Pediatric Anesthesia

 


#ACC22 – RCT: In patients undergoing non-cardiac surgery, a strategy of aggressive intraoperative warming (target core temperature of 37°C) did not reduce major complications compared to routine thermal management (target of 35·5°C).

5 Apr, 2022 | 09:57h | UTC

Aggressive intraoperative warming versus routine thermal management during non-cardiac surgery (PROTECT): a multicentre, parallel group, superiority trial – The Lancet (free registration required)

Commentary: PROTECT: Aggressive Warming During Surgery Does Not Reduce Major Complications – American College of Cardiology

 


Consensus Statement: Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis.

5 Apr, 2022 | 09:54h | UTC

Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study Forum and Academy of Pulmonary Sciences, India – The Lancet Infectious Diseases

 


Perspective: The evidence on 4th doses of covid vaccines & the thorny question of age thresholds.

5 Apr, 2022 | 09:46h | UTC

The Evidence On 4th Doses of Covid Vaccines & the Thorny Question of Age Thresholds – Absolutely Maybe Blog, by Hilda Bastian

Related:

U.S. approves second Covid-19 booster for people 50 and older and immunocompromised individuals.

[Preprint] Retrospective cohort study: second booster vaccine and Covid-19 mortality in adults 60 to 100 years old.

Among health care workers, a fourth dose vaccine effectiveness against any SARS-CoV-2 Omicron variant infection was 30% for the Pfizer–BioNTech and 11% for the Moderna.

[Preprint] Fourth dose of COVID vaccine offers only slight boost against Omicron infection.

Covid-19: Fourth vaccine doses—who needs them and why?

[Not published yet] Study in Israel finds fourth COVID booster has limited efficacy.

 

Commentary on Twitter

https://twitter.com/hildabast/status/1509724907965665280

 


Seminar: Acute coronary syndromes.

5 Apr, 2022 | 09:48h | UTC

Acute coronary syndromes – The Lancet (free for a limited period)

 

Commentary on Twitter

https://twitter.com/TheLancet/status/1510213032143691776

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.